One area of interest is whether ketogenic diets, which are high in fat and low in carbohydrates, might be helpful to people ...

The IQVIA analysis finds that the impact of drug price negotiation on patients’ out-of-pocket spending could also be smaller ...

In an effort to promote research that would help fill this gap, the National Multiple Sclerosis Society has dedicated $4.6 ...

The 2024 increase is the same as last year.The foundation’s annual survey of employer health benefits also found that only 18 ...

Managed Healthcare Executive provides C-suite executives at health plans and provider organizations with news, analysis, ...

Bayer announced today that the FDA has accepted their new drug application (NDA) for menopause drug, elinzanetant, to treat ...

Studies measuring patient preference stacked up in subcutaneous administration’s favor, according to a recently published ...

The results showed that 26% of patients who received tulisokibart achieved clinical remission at week 12 compared with 1% of ...

The higher dose led to a more rapid decline in an important marker of neurodegeneration, according to a Biogen news release ...

Sanjula Jain of Trilliant Health talks about how employers are best positioned to demand value for money from the U.S.

A review of skeletal muscle relaxants shows that they don't work for pain from osteoarthritis, neuropathic pain and other ...

Early trial data of two virally suppressed, breast-feeding women with HIV shows that there may be less of a risk of HIV ...